medigraphic.com
ISSN 2448-8909 (Print)

2023, Number 4

<< Back Next >>

Med Crit 2023; 37 (4)

Incidence and risk factors associated with acute kidney injury and severe acute respiratory syndrome with SARS-CoV-2 in postpartum patient

Ríos NM, López DW, Adaya LEA

Language: Spanish
References: 32
Page: 299-309
PDF size: 266.15 Kb.


ABSTRACT

Introduction: SARS-CoV-2 infection presents a different evolution in each patient, however, a marker of severity is the development of acute kidney injury network (AKIN) where in the general population an incidence near to 50% is reported in those patients admitted to the Intensive Care Unit, which when combined with the puerperium and severe Acute respiratory distress syndrome are parameters of poor prognosis Objective: to analyze the incidence and risk factors associated with acute kidney injury in severe SARS-CoV-2 ARDS in postpartum women. Material and methods: this study is a retrospective analytical case series. The analysis included cases from January 1, 2020 to January 1, 2022. The statistical procedure was carried out with descriptive statistics according to the type of qualitative or quantitative data. Results: the general incidence of the population with AKIN was 0.26% during 2020 to 2021. The obstetric complication with the highest incidence was hypertensive states with n = 4 (36.4%), the affected systems were cardio hemodynamic, nephrourinary and respiratory in n = 11 (100.0%). The average age was 33.66 ± 4.31. During the follow-up of the patients, n = 3 (27.3%) cases of maternal mortality, according to the AKIN classification, one case of AKIN I and two cases of AKIN II. Conclusion: there were 3 cases of mortality in the analyzed population, however, two of them had an AKIN II classification vs one with AKIN I; and the patients did not present lower levels of albumin and/or creatinine upon admission, so it could not be taken into account as a predictor of mortality.


REFERENCES

  1. Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021;101(1):303-318.

  2. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526-2533.

  3. Nadim MK, Forni LG, Mehta RL, Connor MJ, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury: consensus report of the 25th acute disease quality initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16(12):747-764.

  4. Bajpai D, Shah S. COVID-19 pandemic and pregnancy in kidney disease. Adv Chronic Kidney Dis. 2020;27(5):397-403.

  5. Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222(6):521-531.

  6. Instituto Nacional de Salud. Boletín epidemiológico semanal. 2021; Semana 52: 1-29.

  7. De Buhren H, Hertig A. Staging pregnancy-related acute kidney injury according to kidney disease: improving global outcomes guidelines: what are the barriers? Nephrol Dial Transplant. 2021;36(6):959-961.

  8. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209-218.

  9. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol. 2020;45(8):1-21.

  10. Sánchez-álvarez E, Quiroga B, Sequera D. Posicionamiento de la Sociedad Española de Nefrología ante la vacunación frente al SARS-CoV-2. Nefrología. 2021;41(4):412-416.

  11. Wang F, Ran L, Qian C, Hua J, Luo Z, Ding M, et al. Epidemiology and outcomes of acute kidney injury in COVID-19 patients with acute respiratory distress syndrome: a multicenter retrospective study. Blood Purif. 2021;50(4-5):499-505.

  12. Kellum JA, Sileanu FE, Bihorac A, Hoste EAJ, Chawla LS. Recovery after acute kidney injury. Am J Respir Crit Care Med. 2017;195(6):784-791.

  13. Ng JH, Bijol V, Sparks MA, Sise ME, Izzedine H, Jhaveri KD. Pathophysiology and pathology of acute kidney injury in patients with COVID-19. Adv Chronic Kidney Dis. 2020;27(5):365-376.

  14. Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339-1348.

  15. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394(10212):1949-1964.

  16. Emlet DR, Pastor-Soler N, Marciszyn A, Wen X, Gomez H, Humphries WH, et al. Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: Differential expression and secretion in human kidney tubule cells. Am J Physiol Renal Physiol. 2017;312(2):F284-296.

  17. Gao Y dong, Ding M, Dong X, Zhang J jin, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76(2):428-455.

  18. Kellum JA. Diagnostic criteria for acute Kidney injury: Present and future. Crit Care Clin. 2015;31(4):621-32.

  19. Murugan R, Karajala-Subramanyam V, Lee M, Yende S, Kong L, Carter M, et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 2010;77(6):527-535.

  20. Butz AM, Christopher S. von Bartheld JB and SHH. Sepsis-induced acute kidney injury. Physiol Behav. 2017;176(12):139-148.

  21. Ronco C, Bellomo R, Kellum J. Understanding renal functional reserve. Intensive Care Med. 2017;43(6):917-920.

  22. Sawhney S, Marks A, Fluck N, Levin A, Prescott G, Black C. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study. Am J Kidney Dis. 2017;69(1):18-28.

  23. Johnson ACM, Zager RA. Mechanisms underlying increased TIMP2 and IGFBP7 urinary excretion in experimental AKI. J Am Soc Nephrol. 2018;29(8):2157-2167.

  24. Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Vol. 46, Intensive Care Medicine. Springer; 2020. p. 1339-1348.

  25. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. 2020; Available from: https://jamanetwork.com/

  26. Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J Xing, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. Available from: /pmc/articles/PMC7092819/

  27. Bartolomé AÁ, Kassab NAA, Melguizo SC, Conty ML de la C, Acebal LF, Saiz AA, et al. Critical care in SARS-CoV-2 infected pregnant women: a prospective multicenter study. Biomedicines. 2022;10(2):475.

  28. Syeda, S. Baptiste C, Breslin N, Gyamfi-Bannerman, Miller R. The clinical course of COVID in pregnancy. Semin Perinatol. 2020;44(7):151284. doi: 10.1016/j.semperi.2020.151284.

  29. Van Genderen ME, van Uitert E, Duvekot JJ, Gommers D, Sande D van de, Bommel J van, et al. Management and outcome of critically ill pregnant women with COVID-19. Intensive Care Medicine. Springer Science and Business Media Deutschland GmbH; 2022.

  30. Sutton D, Bertozzi-Villa C, Lasky J, Fuchs K, Friedman A. Outcomes and epidemiology of COVID-19 infection in the obstetric population. Semin Perinatol. 2020;44(7):151283. doi: 10.1016/j.semperi.2020.151283.

  31. Garza-Veloz I, Castruita-De la Rosa C, Cortes-Flores R, Martinez-Gaytan V, Rivera-Muñoz JE, Garcia-Mayorga EA, et al. No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy and Childbirth. 2011;11:35. Available from: /pmc/articles/PMC3112063/

  32. Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, et al. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31(3):e2176.




2020     |     www.medigraphic.com